Improving access to HIV prevention medication for at-risk women
Using Audience Segmentation to Identify Implementation Strategies to Improve PrEP Uptake Among At-Risk Cisgender Women
This study is looking for ways to help more women at risk of HIV get access to a preventive medication called PrEP, by finding the best methods to offer it in healthcare settings that focus on women's health.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10691219 on NIH RePORTER |
What this research studies
This research focuses on increasing the uptake of pre-exposure prophylaxis (PrEP) among cisgender women who are at risk of HIV infection. It aims to identify effective strategies for implementing PrEP in various healthcare settings, particularly those that cater to women's sexual and reproductive health. By using audience segmentation, the study will categorize healthcare providers based on their specific needs and organizational environments, allowing for tailored approaches to improve PrEP delivery. The ultimate goal is to enhance awareness and prescription rates of PrEP among eligible women.
Who could benefit from this research
Good fit: Ideal candidates for this research are cisgender women who are at risk for HIV and have not yet been prescribed PrEP.
Not a fit: Patients who are not at risk for HIV or those who are already receiving PrEP may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of at-risk women receiving PrEP, thereby reducing the incidence of HIV infections in this population.
How similar studies have performed: Previous research has shown that targeted implementation strategies can effectively increase PrEP uptake among specific populations, suggesting that this approach may yield positive results.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Pellowski, Jennifer Ann — Brown University
- Study coordinator: Pellowski, Jennifer Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.